Centers for Medicare and Medicaid Services COO Kim Brandt talked about her agency’s use cases for artificial intelligence in the ongoing battle against fraudulent medical claims. The Centers for ...
Medicare negotiated the price of 10 popular medications to save enrollees money. Even more medications are scheduled for ...
The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.
• The agency also extended the deadline for drugmakers to enter participation agreements to July 17, from June 30. • CMS ...
The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
MedPage Today on MSN
What to know about Medicare's hemp-derived product program
Providers will pay for the medications, which are only available to certain enrollees ...
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...
The Centers for Medicare & Medicaid Services (CMS) will extend its temporary Medicare GLP-1 Bridge program for obesity drug coverage through the end of 2027, delaying the launch of a longer-term model ...
Industry stakeholders left a recent meeting with Centers for Medicare & Medicaid Services (CMS) Administrator Dr. Mehmet Oz ...
The Legislative Budget Commission on Tuesday approved two requests from the Agency for Health Care Administration to give it ...
NEW YORK (AP) — The Trump administration will require all 50 states to explain their plans to revalidate some of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results